More clarity is needed on some aspects, he says. "Sebi has not given any clarity on platforms other than social media. If I am able to bring people, let's say on a Zoom platform or if I am able to ...

Following are lists of January's best and worst-performing stocks in the S&P 500 SPX. And further down is a close look at performance and valuations for the index and its 11 sectors. All investment ...

Nobody saw DeepSeek coming and doing the same thing” as OpenAI, but with what looked like cheaper, less powerful chips, said Rob Arnott, founder and chairman of Research Affi ...

Learn more about whether Driven Brands Holdings Inc. or HNI Corporation is a better investment based on AAII's A+ Investor ...

The marathon Q&A sessions are back, along with the cream Oval Office rug and the Diet Coke button on the Resolute Desk. So, ...

Analysts have set 12-month price targets for Clorox, revealing an average target of $158.17, a high estimate of $171.00, and ...

Analysts have set 12-month price targets for Nasdaq, revealing an average target of $90.64, a high estimate of $98.00, and a ...

Investors also assessed a return to a tougher tone on tariffs from President Donald Trump, ahead of the start of a Federal Reserve meeting ...

US stocks plummeted on Monday following the news of a new artificial intelligence app from a Chinese startup, DeepSeek.

The news that DeepSeek was able to develop generative AI technology for far less money than OpenAI spent on ChatGPT has investors concerned that the hardware build-out that enabled Nvidia's stunning ...

The exploration below 154.0 did not last long though, and the broader dollar rebound – which accelerated as universal tariffs ...

Having finally won US marketing approval, Cyclopharm has signed up the nation's biggest private and public hospital groups.